Dabigatran Etexilate

• Catalog number
  B2552-50
• Price
  Please ask
• Size
  50 mg

• Alternative_name
  BIBR 953, (E)-ethyl 3-(2-(((4-(N'-((hexyloxy)carbonyl)carbamimidoyl)phenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate, BIBR953, Pradaxa, BIBR-953
• Description
  Dabigatran is a reversible and selective, direct thrombin inhibitor (DTI) with Ki value of 4.5 nM. Dabigatran selectively and reversibly inhibits human thrombin (Ki = 4.5 nM) as well as thrombin-induced platelet aggregation (IC50 = 10 nM), while showing no inhibitory effect on other platelet-stimulating agents. Dabigatran displays concentration-dependent anticoagulant effects in various species in vitro.
• CAS Number
  211915-06-9
• Structure Available
  Yes
• Molecular Formula
  C₃₄H₄₁N₇O₅
• Molecular Weight
  627.73
• Cell Permeable
  True
• Purity
  ≥98%
• Solubilities
  0.5 mg/ml in DMSO
• Handling
  Do not take internally. Wear gloves and mask when handling the product! Avoid contact by all modes of exposure.
• Tag Line
  A reversible and selective, direct thrombin inhibitor (DTI)
• Storage Condition
  -20ºC
• Shipping Condition
  Gel Pack
• Shelf Life
  36 months
• PubChem CID
  6445226
• PubChem CID Link
• SMILES
  CCCCCCOC(=O)N=C(C1=CC=C(C=C1)NCC2=NC3=C(N2C)C=CC(=C3)C(=O)N(CCC(=O)OCC)C4=CC=CC=N4)N
• InChi
  InChI=1S/C34H41N7O5/c1-4-6-7-10-21-46-34(44)39-32(35)24-12-15-26(16-13-24)37-23-30-38-27-22-25(14-17-28(27)40(30)3)33(43)41(20-18-31(42)45-5-2)29-11-8-9-19-36-29/h8-9,11-17,19,22,37H,4-7,10,18,20-21,23H2,1-3H3,(H2,35,39,44)
• InChi Key
  KSGXQBZTULBEEQ-UHFFFAOYSA-N
• Data Sheet Link
• MSDS Available
  True

• Gene target
  Dabigatran   Etexilate  
• Short name
  Dabigatran Etexilate
• Alternative name
  Dabigatran Etexilate

Product images

Similar products